Invesco
ACET icon

Invesco’s Adicet Bio ACET Stock Holding History

Invesco’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-777
Closed -$29.2K – 3870
2024
Q1 		$29.2K Buy
777
+124
+19% +$5.13K ﹤0.01% 3831
2023
Q4 		$19.7K Buy
+653
New +$14.2K ﹤0.01% 3803
2023
Q1 		– Sell
-635
Closed -$90.8K – 3860
2022
Q4 		$90.8K Buy
+635
New +$158K ﹤0.01% 3846
2022
Q2 		– Sell
-6,464
Closed -$2.06M – 4031
2022
Q1 		$2.06M Buy
+6,464
New +$1.49M ﹤0.01% 2772
2019
Q4 		– Sell
-38,571
Closed -$38.2M – 3647
2019
Q3 		$38.2M Buy
38,571
+10
+0% +$11.2K 0.01% 1107
2019
Q2 		$44.1M Buy
+38,561
New +$35M 0.01% 1080

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Invesco's ACET Position: Q2 2024 in Review

Invesco sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 777 shares — an estimated $29.2K sold.

Invesco first reported a position in ACET in Q2 2019 and held it in 6 quarters. The position peaked at $44.1M in Q2 2019. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Invesco reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 777 Adicet Bio shares in Q2 2024, an estimated $29.2K.
  • Invesco first reported a position in Adicet Bio in Q2 2019 and held it in 6 quarters.
  • Invesco's Adicet Bio position peaked at $44.1M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.